ArticleScientific reports2026
Multistep loss of catalytic and ligand binding abilities of hexameric purine nucleoside phosphorylase.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
It is commonly believed that enzymatic catalysis is such a complex process, that even a small change in any physicochemical property of the enzyme results in a complete loss of the catalytic and ligand-binding capacity of the molecule. Therefore, when the enzyme sample is not fully active, but is electrophoretically pure, the inactive fraction is often considered equal to the non-binding fraction, and constants characterizing ligand binding by such an enzyme and ligand-induced inhibition are determined under this assumption. Here, we present an enzyme, hexameric purine nucleoside phosphorylase, whose gradual loss of a catalytic activity towards natural substrates does not correlate with the loss of the ability to bind ligands, substrates, and inhibitors. The values of dissociation constants characterizing ligand binding depend on the specific activity of the enzyme used in the experiment. Furthermore, there is a stable state of the enzyme, in which it is no longer able to catalyse reaction with natural substrates, but can still catalyse the same reaction if a substrate resembling the transition state is used. The active site conformations of individual subunits in the X-ray structure of this hexameric molecule reflect the presence of intermediate states observed in the enzyme activity decline profiles.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.